0001104659-11-018298.txt : 20110401
0001104659-11-018298.hdr.sgml : 20110401
20110401184157
ACCESSION NUMBER: 0001104659-11-018298
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110401
FILED AS OF DATE: 20110401
DATE AS OF CHANGE: 20110401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANZYME INC
CENTRAL INDEX KEY: 0001274644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 631192270
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4819 EMPEROR BOULEVARD, SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919 313-4760
MAIL ADDRESS:
STREET 1: 4819 EMPEROR BOULEVARD, SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Desjardins-Innovatech S.E.C.
CENTRAL INDEX KEY: 0001516029
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35119
FILM NUMBER: 11733048
BUSINESS ADDRESS:
STREET 1: 2 COMPLEXE DESJARDINS, #1717
STREET 2: P.O. BOX 760
CITY: MONTREAL
STATE: A8
ZIP: H5B 1B8
BUSINESS PHONE: 15142817131
MAIL ADDRESS:
STREET 1: 2 COMPLEXE DESJARDINS, #1717
STREET 2: P.O. BOX 760
CITY: MONTREAL
STATE: A8
ZIP: H5B 1B8
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Capital regional et cooperatif Desjardins
CENTRAL INDEX KEY: 0001516038
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35119
FILM NUMBER: 11733049
BUSINESS ADDRESS:
STREET 1: 2 COMPLEXE DESJARDINS, #1717
STREET 2: P.O. BOX 760
CITY: MONTREAL
STATE: A8
ZIP: H5B 1B8
BUSINESS PHONE: 15142817131
MAIL ADDRESS:
STREET 1: 2 COMPLEXE DESJARDINS, #1717
STREET 2: P.O. BOX 760
CITY: MONTREAL
STATE: A8
ZIP: H5B 1B8
3
1
a3.xml
3
X0203
3
2011-04-01
0
0001274644
TRANZYME INC
TZYM
0001516038
Capital regional et cooperatif Desjardins
2 COMPLEXE DESJARDINS, #1717
P.O. BOX 760
MONTREAL, QUEBEC, CANADA
H5B 1B8
0
0
1
0
0001516029
Desjardins-Innovatech S.E.C.
2 COMPLEXE DESJARDINS, #1717
P.O. BOX 760
MONTREAL, QUEBEC, CANADA
H5B 1B8
0
0
1
0
Common Exchangeable Shares of Tranzyme Pharma Inc.
Common Stock
14497
D
Preferred Exchangeable Shares of Tranzyme Pharma Inc.
Common Exchangeable Shares of Tranzyme Pharma Inc.
1217804
D
Common Exchangeable Shares of Tranzyme Pharma Inc.
Common Stock
29721
I
By Desjardins-Innovatech S.E.C.
These shares of Tranzyme Pharma Inc. will be exchanged for shares of Common Stock of the Issuer upon the closing of the Issuer's initial public offering, which is anticipated to occur on April 6, 2011, in a corporate reorganization. These shares are immediately exercisable and have no expiration date.
These shares of Tranzyme Pharma Inc. will be converted into Common Exchangeable Shares of Tranzyme Pharma Inc. immediately prior to the closing of the Issuer's initial public offering, which is anticipated to occur on April 6, 2011, in a corporate reorganization. These shares are immediately exercisable and have no expiration date.
These securities are owned of record by Capital regional et cooperatif Desjardins, and ultimate control over voting and investment determinations with respect to the shares held by Capital regional et cooperatif Desjardins are made by the board of directors of Capital regional et cooperatif Desjardins, which is comprised of the following directors: Marlene Deveaux, Michael Dorosz, Maurice Doyon, Francine Ferland, Josee Fortin, Pierre Gauvreau, Evangeliste Bourdages, Andre Lachapelle, Steve Lepage, Jean-Claude Loranger, Bruno Morin, Jacques Plante and Claudine Roy, each of whom disclaims beneficial ownership of such securities except to the extent of his or her pecuniary interest therein.
These securities are owned of record by Desjardins-Innovatech S.E.C. Ultimate control over voting and investment determinations with respect to the shares held by Desjardins-Innovatech S.E.C. are made by the board of directors of Capital regional et cooperatif Desjardins, which is comprised of the following directors: Marlene Deveaux, Michael Dorosz, Maurice Doyon, Francine Ferland, Josee Fortin, Pierre Gauvreau, Evangeliste Bourdages, Andre Lachapelle, Steve Lepage, Jean-Claude Loranger, Bruno Morin, Jacques Plante and Claudine Roy, each of whom disclaims beneficial ownership of such securities except to the extent of his or her pecuniary interest therein.
/s/ Renaud Lebuis, Legal Advisor and /s/ Gerald St. Aubin, Vice-President for Capital regional et cooperatif Desjardins
2011-04-01
/s/ Renaud Lebuis, Legal Advisor and /s/ Gerald St. Aubin, Vice-President for Desjardins - Innovatech S.E.C.
2011-04-01